164 NHL Fights, a Dementia Diagnosis at 30 & the Breakthrough That Saved Daniel Carcillo's Life

I've had a lot of conversations that mattered to me personally, but few have hit the way this one did. Daniel Carcillo and I sat down recently, and I'll be honest — I've admired him from a distance for years before I ever got the chance to talk to him directly. Two-time Stanley Cup champion, 164 fights over a ten-year NHL career, and now one of the most credible voices in psychedelic-assisted therapy for brain trauma. That's not a normal career arc. But it's exactly the kind of story this show exists to tell.

The cost nobody puts on the highlight reel

If you look up Daniel's career, you'll find some of the most physically dominant footage you can watch. What you won't find in those clips is what it actually cost him. Seven diagnosed concussions. An early onset dementia diagnosis at 30. Light sensitivity, slurred speech, insomnia, impulse control issues, suicidal ideation. He was forced into retirement in 2015 carrying all of it at once.

What struck me most wasn't the list of symptoms — it was what he said about the culture that produced them. In the NHL, fighting wasn't chaos. It was code. You take the hit to make the play. You don't want teammates who won't commit to contact, because everyone sees it, and everyone knows the game is lost before it starts. Daniel described loving that world — the will, the eye contact, the ability to sit comfortably inside genuine physical danger. That identity served a real purpose for a decade. The question I wanted to ask him was what happens when the game ends and that identity doesn't just switch off.

Four years of trying everything

Daniel's transition out of hockey wasn't a rough patch. He called it the hardest four years of his life. He went through round after round of pharmaceutical prescriptions, switching cocktails as symptoms shifted, until he stopped everything cold turkey and had seizures as a result. He tried stroke rehab, concussion clinics charging fifteen hundred dollars a day, craniosacral therapy, acupuncture, float tanks, hyperbaric chambers. By his own estimate, he was three hundred thousand dollars deep into treatments that weren't fixing the actual problem. Neurologists told him this was his new normal and there wasn't much more they could do.

That's the line that got me — because I've sat across from that exact kind of exhaustion before, in my own life and in the people I work with. There's a specific despair that comes from doing everything you're told to do and still not getting better.

The paper that changed everything

What turned things around for Daniel was a PubMed paper out of Imperial College London, led by researcher Robin Carhart-Harris, showing brain hemisphere connectivity on psilocybin that hadn't been documented before. He described it as a light going off. So he took an invitation to a farm in Colorado, ran full diagnostics beforehand — bloodwork, a QEG brain scan — and went through two high-dose sessions three months apart, with a structured microdosing washout period in between.

At the six-month mark, the same neurologist who'd told him to accept a new normal ran the scans again. No abnormalities. Bloodwork clean. His free testosterone, which had been sitting at the level of a 72-year-old, came back up 1200 percent to that of a 35-year-old. Cortisol normalized. He stopped needing the dark glasses he'd relied on for light sensitivity. He could tolerate his kids crying and yelling in the same room without his nervous system spiking.

I want to be careful here, because Daniel was careful too. This isn't a magic pill story, and he'd be the first to say it. The data backs the mechanism — Johns Hopkins research shows roughly 80 percent of participants in one study no longer qualified for depression a year out, compared to conventional SSRIs that work in the range of single digits to maybe 7 percent of cases for treatment-resistant depression. The FDA has already granted breakthrough therapy designation to psilocybin for major depressive disorder. That gap in outcomes is not a small thing, and it's genuinely underreported.

Why the medicine isn't the whole story

The part of the conversation I keep coming back to is what Daniel said about integration. He was direct: this only works if you pair it with real psychotherapy, real lifestyle change, and people around you who are actually living an active, intentional life. He runs Experience Onward, a legal psilocybin service center in Portland, and he won't take on someone who doesn't already have a therapist or coach back home. Preparation, screening, facilitator matching, and months of structured follow-up — nutrition protocols, mindfulness practice, movement — all of it exists because the ceremony itself is only the doorway. What you do with the weeks and months after is the actual work.

That distinction matters to me, because it's the same principle underneath everything we do at Elevétion. There's no version of real physiological change that doesn't require discipline on the other side of it. Motivation gets you in the door. Discipline is what happens when it's hard and you do it anyway.

What I took from this

Near the end of our conversation, I asked Daniel what he'd tell himself the day he retired, knowing what he knows now. His answer: don't go on pharmaceuticals so fast. Do the research first. And when I asked about legacy, he didn't mention any of it — the Cups, the fights, the company. He said he just wants to be a good dad, and a person his kids can come to with anything.

That's the thread I want people to sit with. Daniel's story isn't really about mushrooms. It's about what happens when someone refuses to accept "there's nothing more we can do for you" as a final answer, and does the harder work of finding out what's actually true. That refusal is the whole point of this show.